Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.

作者: Morad-Rémy Muhsin-Sharafaldine , Bailey R. Kennedy , Sarah C. Saunderson , Catrin R. Buchanan , Amy C. Dunn

DOI: 10.1016/J.BBAGEN.2016.11.020

关键词: TenaseProthrombinaseCancer researchCoagulationTissue factorFactor VPhosphatidylserineImmunologyThrombinThromboplastinBiology

摘要: Abstract Background Chemotherapy induces the release of apoptotic vesicles (ApoV) from tumor plasma membrane. Tumor ApoV may enhance risk thrombotic events in cancer patients undergoing chemotherapy. However, relative contribution to coagulation and pathways involved remain poorly characterized. In addition, this study sets out compare procoagulant activity chemotherapy-induced with their cell origin determine mechanisms ApoV-induced coagulation. Methods We utilized human murine lines chemotherapeutic agents requirement for factors (tissue factor; TF, FII, FV, FVII, FVIII, FIX phosphatidylserine) ApoV. The role previously identified ApoV-associated FV was determined a functional assay. Results were significantly more per microgram protein compared parental living or dying cells. phase peak fibrin generation, dependent on phosphatidylserine, TF expression, FVII prothrombinase complex. intrinsic FVIII dispensable. could not support absence supplied, exogenous FV. Conclusions are than require extrinsic tenase complex activate early Endogenous is serum-derived functional, but non-essential ApoV-mediated generation. General significance This clarifies released

参考文章(70)
P.B. Tracy, J.M. Peterson, M.E. Nesheim, F.C. McDuffie, K.G. Mann, Interaction of coagulation factor V and factor Va with platelets. Journal of Biological Chemistry. ,vol. 254, pp. 10354- 10361 ,(1979) , 10.1016/S0021-9258(19)86716-9
Rodney M. Camire, Eleanor S. Pollak, Kenneth Kaushansky, Paula B. Tracy, Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool Blood. ,vol. 92, pp. 3035- 3041 ,(1998) , 10.1182/BLOOD.V92.9.3035
V J J Bom, J H Reinalda-Poot, R Cupers, R M Bertina, EXTRINSIC ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-IX AND FACTOR-X Thrombosis and Haemostasis. ,vol. 63, pp. 224- 230 ,(1990) , 10.1055/S-0038-1645199
MD Rand, JB Lock, C van't Veer, DP Gaffney, KG Mann, Blood clotting in minimally altered whole blood Blood. ,vol. 88, pp. 3432- 3445 ,(1996) , 10.1182/BLOOD.V88.9.3432.BLOODJOURNAL8893432
J. H. Morrissey, S. A. Smith, Polyphosphate as modulator of hemostasis, thrombosis, and inflammation. Journal of Thrombosis and Haemostasis. ,vol. 13, ,(2015) , 10.1111/JTH.12896
Wei‐Xiang Qi, Feng Lin, Yuan‐Jue Sun, Li‐Na Tang, Zan Shen, Yang Yao, None, Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis British Journal of Clinical Pharmacology. ,vol. 76, pp. 338- 347 ,(2013) , 10.1111/BCP.12203
M. M. ALEMAN, C. GARDINER, P. HARRISON, A. S. WOLBERG, Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability Journal of Thrombosis and Haemostasis. ,vol. 9, pp. 2251- 2261 ,(2011) , 10.1111/J.1538-7836.2011.04488.X
Alok A. Khorana, Charles W. Francis, Eva Culakova, Gary H. Lyman, Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer. ,vol. 104, pp. 2822- 2829 ,(2005) , 10.1002/CNCR.21496
G. M. Thomas, A. Brill, S. Mezouar, L. Crescence, M. Gallant, C. Dubois, D. D. Wagner, Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. Journal of Thrombosis and Haemostasis. ,vol. 13, pp. 1310- 1319 ,(2015) , 10.1111/JTH.13002
Ikrame Lazar, Emily Clement, Manuelle Ducoux-Petit, Laurence Denat, Vanessa Soldan, Stéphanie Dauvillier, Stéphanie Balor, Odile Burlet-Schiltz, Lionel Larue, Catherine Muller, Laurence Nieto, Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell & Melanoma Research. ,vol. 28, pp. 464- 475 ,(2015) , 10.1111/PCMR.12380